beta-Adrenergic Blocker [EPC]

beta-Adrenergic Blocker [EPC] was reported 306053 times

Drugs of the beta-Adrenergic Blocker [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 313 0.2947
1 HYPERPARATHYROIDISM SECONDARY 706 0.2815
2 NEPHROGENIC ANAEMIA 1304 0.2812
3 BRASH SYNDROME 372 0.2650
4 CARDIOACTIVE DRUG LEVEL INCREASED 209 0.1589
5 REBOUND ACID HYPERSECRETION 467 0.1542
6 ISCHAEMIC CARDIOMYOPATHY 473 0.1541
7 ESSENTIAL HYPERTENSION 272 0.1485
8 END STAGE RENAL DISEASE 2458 0.1346
9 FEMALE GENITAL TRACT FISTULA 217 0.1270
10 HAEMORRHAGIC ANAEMIA 524 0.1191
11 RADICULOPATHY 314 0.1190
12 ORTHOPNOEA 360 0.1129
13 LEFT VENTRICULAR HYPERTROPHY 447 0.1043
14 CHRONIC SINUSITIS 387 0.1030
15 BLOOD PRESSURE INADEQUATELY CONTROLLED 614 0.1020
16 ATRIOVENTRICULAR BLOCK FIRST DEGREE 433 0.0998
17 DIASTOLIC DYSFUNCTION 303 0.0981
18 SINUS BRADYCARDIA 934 0.0965
19 BUNDLE BRANCH BLOCK LEFT 409 0.0963
20 MACULAR DEGENERATION 1136 0.0950
21 CARDIAC FAILURE CHRONIC 404 0.0947
22 VENTRICULAR HYPOKINESIA 297 0.0924
23 MITRAL VALVE INCOMPETENCE 1034 0.0913
24 RENAL FAILURE CHRONIC 682 0.0886
25 BRADYCARDIA 4549 0.0857
26 CAROTID ARTERY STENOSIS 298 0.0852
27 AORTIC VALVE INCOMPETENCE 361 0.0848
28 AORTIC ARTERIOSCLEROSIS 218 0.0846
29 CARDIOMEGALY 1042 0.0846
30 CHRONIC KIDNEY DISEASE 6426 0.0845
31 DIABETIC NEUROPATHY 409 0.0825
32 CONGESTIVE CARDIOMYOPATHY 341 0.0817
33 ANGINA UNSTABLE 531 0.0816
34 TRICUSPID VALVE INCOMPETENCE 644 0.0810
35 THERAPEUTIC AGENT TOXICITY 270 0.0809
36 CARDIAC FAILURE CONGESTIVE 6359 0.0791
37 PROCTITIS 220 0.0785
38 CORONARY ARTERY STENOSIS 393 0.0781
39 BLOOD CHLORIDE DECREASED 201 0.0779
40 CORONARY ARTERY DISEASE 2345 0.0774
41 VENTRICULAR DYSFUNCTION 198 0.0762
42 EJECTION FRACTION DECREASED 1160 0.0746
43 HYPERKALAEMIA 2596 0.0740
44 BRAIN NATRIURETIC PEPTIDE INCREASED 221 0.0716
45 CORONARY ARTERIAL STENT INSERTION 362 0.0713
46 CORONARY ARTERY OCCLUSION 979 0.0713
47 SUPRAVENTRICULAR EXTRASYSTOLES 239 0.0707
48 VARICES OESOPHAGEAL 209 0.0690
49 PERIPHERAL VASCULAR DISORDER 353 0.0685
50 ATRIOVENTRICULAR BLOCK 527 0.0681
51 DIVERTICULUM 483 0.0679
52 CARDIOMYOPATHY 1004 0.0679
53 LEFT VENTRICULAR DYSFUNCTION 454 0.0677
54 BREATH SOUNDS ABNORMAL 334 0.0677
55 HYPERLIPIDAEMIA 806 0.0674
56 RALES 386 0.0664
57 LEFT VENTRICULAR FAILURE 228 0.0662
58 HYPOVOLAEMIA 386 0.0659
59 BLOOD POTASSIUM INCREASED 1061 0.0653
60 DYSLIPIDAEMIA 330 0.0649
61 NEPHROGENIC SYSTEMIC FIBROSIS 195 0.0645
62 RENAL FAILURE ACUTE 2737 0.0644
63 ARTERIOSCLEROSIS CORONARY ARTERY 427 0.0644
64 RENAL INJURY 1906 0.0641
65 BLOOD UREA INCREASED 1065 0.0635
66 ARTERIOSCLEROSIS 597 0.0634
67 AZOTAEMIA 251 0.0628
68 AORTIC STENOSIS 218 0.0625
69 HYPERTENSIVE CRISIS 696 0.0625
70 LOW BIRTH WEIGHT BABY 497 0.0625
71 CARDIOGENIC SHOCK 896 0.0624
72 ACUTE MYOCARDIAL INFARCTION 1838 0.0623
73 INTERNATIONAL NORMALISED RATIO DECREASED 252 0.0622
74 ATRIOVENTRICULAR BLOCK COMPLETE 414 0.0618
75 LOWER GASTROINTESTINAL HAEMORRHAGE 454 0.0614
76 VENTRICULAR EXTRASYSTOLES 633 0.0609
77 DIVERTICULUM INTESTINAL 266 0.0608
78 ATRIAL FLUTTER 482 0.0603
79 MYOCARDIAL ISCHAEMIA 682 0.0599
80 SPINAL OSTEOARTHRITIS 523 0.0595
81 HYPOMAGNESAEMIA 823 0.0591
82 RENAL CYST 469 0.0590
83 VENTRICULAR TACHYCARDIA 973 0.0589
84 POTENTIATING DRUG INTERACTION 195 0.0581
85 EXERCISE TOLERANCE DECREASED 334 0.0580
86 HIGH DENSITY LIPOPROTEIN DECREASED 193 0.0579
87 ORTHOSTATIC HYPOTENSION 1005 0.0577
88 PRE-ECLAMPSIA 273 0.0574
89 INTERNATIONAL NORMALISED RATIO INCREASED 1633 0.0572
90 CEREBRAL HAEMATOMA 192 0.0571
91 RENAL FAILURE 7552 0.0568
92 ELECTROCARDIOGRAM ABNORMAL 440 0.0560
93 HEART RATE DECREASED 1969 0.0560
94 UPPER GASTROINTESTINAL HAEMORRHAGE 943 0.0560
95 ACUTE KIDNEY INJURY 8525 0.0557
96 SUSPECTED SUICIDE 261 0.0556
97 ANGINA PECTORIS 1592 0.0555
98 BENIGN PROSTATIC HYPERPLASIA 286 0.0553
99 ARTERIAL OCCLUSIVE DISEASE 434 0.0552
100 CARDIAC FAILURE ACUTE 367 0.0550
101 CAROTID ARTERY OCCLUSION 201 0.0550
102 BLOOD PRESSURE SYSTOLIC DECREASED 249 0.0547
103 BLOOD PRESSURE DIASTOLIC DECREASED 401 0.0543
104 BUNDLE BRANCH BLOCK RIGHT 246 0.0535
105 ECONOMIC PROBLEM 810 0.0534
106 CORONARY ARTERY BYPASS 307 0.0533
107 MULTIPLE INJURIES 335 0.0531
108 HYPOTENSION 10649 0.0530
109 VENTRICULAR ARRHYTHMIA 194 0.0530
110 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 216 0.0529
111 NEPHROPATHY 493 0.0527
112 ATRIAL FIBRILLATION 5086 0.0522
113 ATELECTASIS 503 0.0520
114 PULSE ABSENT 247 0.0519
115 AORTIC ANEURYSM 395 0.0519
116 HAEMATOCRIT DECREASED 1028 0.0518
117 BLOOD URIC ACID INCREASED 297 0.0514
118 CARDIAC VALVE DISEASE 294 0.0514
119 CARDIAC MURMUR 445 0.0514
120 IRON DEFICIENCY ANAEMIA 473 0.0512
121 BODY HEIGHT DECREASED 546 0.0510
122 RENAL TUBULAR NECROSIS 499 0.0508
123 PROTHROMBIN TIME PROLONGED 302 0.0504
124 CARDIAC FAILURE 4015 0.0500
125 GOUT 886 0.0493
126 PULMONARY OEDEMA 2209 0.0493
127 EXTRASYSTOLES 342 0.0489
128 BLOOD PRESSURE SYSTOLIC INCREASED 941 0.0482
129 ACUTE PULMONARY OEDEMA 270 0.0481
130 VENTRICULAR FIBRILLATION 533 0.0479
131 SPINAL COLUMN STENOSIS 225 0.0476
132 GLOMERULAR FILTRATION RATE DECREASED 580 0.0472
133 BLOOD PRESSURE FLUCTUATION 1131 0.0471
134 BLOOD CREATININE INCREASED 3064 0.0469
135 PULMONARY HYPERTENSION 974 0.0467
136 CARDIAC PACEMAKER INSERTION 278 0.0466
137 GASTROINTESTINAL HAEMORRHAGE 3893 0.0465
138 GASTRITIS EROSIVE 217 0.0465
139 HEART RATE IRREGULAR 1050 0.0464
140 LARGE INTESTINE POLYP 318 0.0459
141 DIZZINESS POSTURAL 438 0.0451
142 HIATUS HERNIA 584 0.0451
143 ACUTE CORONARY SYNDROME 372 0.0449
144 BLOOD PRESSURE DECREASED 2981 0.0448
145 BLOOD MAGNESIUM DECREASED 387 0.0448
146 HAEMORRHOIDAL HAEMORRHAGE 217 0.0444
147 ISCHAEMIA 204 0.0443
148 PSYCHOLOGICAL TRAUMA 383 0.0443
149 HAEMORRHAGIC STROKE 346 0.0443
150 HAIR DISORDER 365 0.0443
151 ANURIA 380 0.0441
152 HYPONATRAEMIA 2482 0.0440
153 OEDEMA PERIPHERAL 5341 0.0438
154 HYPOVOLAEMIC SHOCK 209 0.0436
155 SLEEP APNOEA SYNDROME 832 0.0436
156 RECTAL HAEMORRHAGE 1866 0.0434
157 PRESYNCOPE 1056 0.0434
158 DIABETES MELLITUS INADEQUATE CONTROL 768 0.0433
159 GASTRIC ULCER HAEMORRHAGE 240 0.0433
160 URINE OUTPUT DECREASED 377 0.0431
161 DUODENAL ULCER 303 0.0429
162 TUBULOINTERSTITIAL NEPHRITIS 803 0.0428
163 MELAENA 942 0.0428
164 BLOOD CHOLESTEROL ABNORMAL 197 0.0426
165 ECCHYMOSIS 292 0.0425
166 SYNCOPE 4259 0.0425
167 BLOOD SODIUM DECREASED 799 0.0423
168 BLOOD PRESSURE INCREASED 6470 0.0423
169 DYSPNOEA EXERTIONAL 1591 0.0422
170 STENT PLACEMENT 339 0.0420
171 COAGULOPATHY 700 0.0420
172 FLUID OVERLOAD 610 0.0419
173 INFARCTION 286 0.0418
174 HYPOKALAEMIA 1927 0.0417
175 SUPRAVENTRICULAR TACHYCARDIA 399 0.0416
176 HYPERTENSION 8814 0.0416
177 POLYP 272 0.0415
178 BLOOD POTASSIUM DECREASED 1249 0.0415
179 SHOCK 955 0.0415
180 NOCTURIA 503 0.0414
181 INTERVERTEBRAL DISC DEGENERATION 382 0.0412
182 HAEMODIALYSIS 346 0.0412
183 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 208 0.0410
184 HYPOGLYCAEMIA 1984 0.0409
185 KIDNEY TRANSPLANT REJECTION 196 0.0408
186 FAILURE TO THRIVE 210 0.0404
187 VISUAL DISTURBANCE 230 0.0400
188 HAEMORRHOIDS 781 0.0400
189 BLOOD PRESSURE ABNORMAL 795 0.0399
190 TROPONIN INCREASED 304 0.0399
191 TRANSIENT ISCHAEMIC ATTACK 1345 0.0398
192 FOETAL GROWTH RESTRICTION 242 0.0398
193 VITAMIN D DEFICIENCY 386 0.0395
194 HAIR COLOUR CHANGES 492 0.0395
195 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 348 0.0393
196 ARRHYTHMIA 1859 0.0392
197 ACUTE RESPIRATORY FAILURE 755 0.0392
198 SUBDURAL HAEMATOMA 561 0.0392
199 STOMACH DISCOMFORT 202 0.0391
200 HEPATIC STEATOSIS 725 0.0389
201 PULMONARY CONGESTION 513 0.0389
202 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 398 0.0387
203 MENTAL STATUS CHANGES 1076 0.0387
204 RENAL IMPAIRMENT 3246 0.0386
205 CARDIAC FLUTTER 249 0.0385
206 HYPERVOLAEMIA 190 0.0384
207 PARAESTHESIA ORAL 554 0.0384
208 BLOOD TRIGLYCERIDES INCREASED 677 0.0383
209 COMPLETED SUICIDE 3191 0.0383
210 ANHEDONIA 1006 0.0382
211 PERIPHERAL COLDNESS 525 0.0382
212 MYOCARDIAL INFARCTION 6643 0.0380
213 INCREASED TENDENCY TO BRUISE 350 0.0380
214 METABOLIC ACIDOSIS 1216 0.0380
215 DRUG INTERACTION 6011 0.0379
216 MULTI-ORGAN FAILURE 653 0.0377
217 SHOCK HAEMORRHAGIC 307 0.0377
218 OVERWEIGHT 202 0.0376
219 LUNG INFILTRATION 331 0.0374
220 HYPOCALCAEMIA 709 0.0374
221 EXOSTOSIS 342 0.0374
222 POLYURIA 306 0.0373
223 PREMATURE DELIVERY 594 0.0373
224 HEART RATE ABNORMAL 208 0.0373
225 RED BLOOD CELL SEDIMENTATION RATE INCREASED 412 0.0372
226 TORSADE DE POINTES 292 0.0372
227 RED BLOOD CELL COUNT DECREASED 1063 0.0371
228 OLIGURIA 230 0.0370
229 OESOPHAGITIS 404 0.0369
230 CHOLECYSTITIS ACUTE 209 0.0368
231 FLUID RETENTION 1870 0.0367
232 RHABDOMYOLYSIS 1524 0.0365
233 PLEURAL EFFUSION 2200 0.0361
234 GASTRITIS 951 0.0361
235 HYPERCHOLESTEROLAEMIA 348 0.0360
236 DIALYSIS 511 0.0360
237 POST-TRAUMATIC STRESS DISORDER 241 0.0359
238 DIABETES MELLITUS 2738 0.0359
239 PERICARDIAL EFFUSION 825 0.0356
240 OSTEOARTHRITIS 1509 0.0356
241 FLANK PAIN 333 0.0355
242 ANAEMIA 6768 0.0354
243 COORDINATION ABNORMAL 494 0.0354
244 CHEST PAIN 6557 0.0354
245 ANOREXIA 456 0.0353
246 CONCOMITANT DISEASE AGGRAVATED 218 0.0353
247 ELECTROLYTE IMBALANCE 410 0.0353
248 ORAL CANDIDIASIS 464 0.0352
249 TYPE 2 DIABETES MELLITUS 1184 0.0351
250 HYPERGLYCAEMIA 1280 0.0351
251 HAEMATOMA 910 0.0351
252 HAIR TEXTURE ABNORMAL 469 0.0350
253 ISCHAEMIC STROKE 625 0.0350
254 HAEMOGLOBIN DECREASED 3594 0.0350
255 BLOOD ALBUMIN DECREASED 277 0.0349
256 GLUCOSE TOLERANCE IMPAIRED 206 0.0348
257 DEHYDRATION 4636 0.0347
258 URINE ODOUR ABNORMAL 204 0.0347
259 BLOOD IRON DECREASED 411 0.0346
260 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1806 0.0346
261 HAEMATURIA 1183 0.0345
262 UNRESPONSIVE TO STIMULI 891 0.0345
263 LOW DENSITY LIPOPROTEIN INCREASED 267 0.0345
264 PRE-EXISTING CONDITION IMPROVED 215 0.0344
265 EPISTAXIS 2557 0.0341
266 CARDIAC ARREST 2811 0.0340
267 DECUBITUS ULCER 276 0.0338
268 BLOOD CHOLESTEROL INCREASED 1576 0.0338
269 HEPATIC ENCEPHALOPATHY 313 0.0335
270 SKIN ULCER 866 0.0335
271 HYPERCALCAEMIA 410 0.0332
272 ULCER 527 0.0331
273 CIRCULATORY COLLAPSE 564 0.0331
274 SPINAL DISORDER 313 0.0330
275 GASTRIC ULCER 627 0.0330
276 FAECES DISCOLOURED 713 0.0329
277 BASAL CELL CARCINOMA 513 0.0328
278 CARDIO-RESPIRATORY ARREST 1374 0.0328
279 INTERNAL HAEMORRHAGE 374 0.0327
280 FEAR 878 0.0326
281 OBESITY 520 0.0326
282 ROTATOR CUFF SYNDROME 417 0.0324
283 GASTROOESOPHAGEAL REFLUX DISEASE 2613 0.0324
284 HAEMODYNAMIC INSTABILITY 246 0.0323
285 ACIDOSIS 246 0.0322
286 SCOLIOSIS 199 0.0321
287 MYOPATHY 277 0.0320
288 CARDIAC DISORDER 3000 0.0320
289 BLOOD URINE PRESENT 608 0.0320
290 POSTOPERATIVE WOUND INFECTION 216 0.0319
291 SQUAMOUS CELL CARCINOMA OF SKIN 193 0.0319
292 MADAROSIS 371 0.0319
293 UROSEPSIS 293 0.0317
294 OEDEMA 1720 0.0317
295 GENERALISED OEDEMA 392 0.0316
296 WEIGHT FLUCTUATION 331 0.0316
297 HYPOPHOSPHATAEMIA 232 0.0314
298 DECREASED ACTIVITY 338 0.0313
299 LACTIC ACIDOSIS 1014 0.0313
300 VITAMIN D DECREASED 267 0.0312
301 PREMATURE BABY 940 0.0312
302 URINARY INCONTINENCE 925 0.0312
303 LEUKOCYTOSIS 564 0.0311
304 FULL BLOOD COUNT DECREASED 627 0.0311
305 FALL 10280 0.0309
306 SUBARACHNOID HAEMORRHAGE 314 0.0308
307 ASCITES 906 0.0308
308 ASTHENIA 11557 0.0307
309 PURPURA 270 0.0305
310 MALNUTRITION 340 0.0304
311 DYSURIA 1118 0.0303
312 HAEMATEMESIS 769 0.0303
313 TEMPERATURE INTOLERANCE 313 0.0303
314 CLOSTRIDIUM DIFFICILE COLITIS 321 0.0302
315 GLYCOSYLATED HAEMOGLOBIN INCREASED 764 0.0302
316 HYPOXIA 1065 0.0302
317 CHOLELITHIASIS 991 0.0302
318 TENDERNESS 314 0.0301
319 RENAL DISORDER 1399 0.0300
320 REFUSAL OF TREATMENT BY PATIENT 196 0.0300
321 MUSCULOSKELETAL PAIN 1572 0.0300
322 EYE HAEMORRHAGE 400 0.0299
323 LYMPHOEDEMA 207 0.0299
324 SCIATICA 477 0.0299
325 INTERVERTEBRAL DISC PROTRUSION 654 0.0299
326 PANCREATITIS ACUTE 667 0.0296
327 PULMONARY FIBROSIS 569 0.0296
328 BONE DISORDER 540 0.0296
329 ABASIA 732 0.0296
330 BLOOD CALCIUM DECREASED 333 0.0296
331 CONTUSION 2850 0.0296
332 CATARACT 1762 0.0296
333 HEPATITIS ACUTE 192 0.0295
334 BURSITIS 358 0.0295
335 BLOOD CREATINE PHOSPHOKINASE INCREASED 847 0.0294
336 BLOOD GLUCOSE FLUCTUATION 322 0.0294
337 ABNORMAL LOSS OF WEIGHT 200 0.0293
338 DIZZINESS 14619 0.0293
339 PETECHIAE 305 0.0292
340 HEPATIC CIRRHOSIS 549 0.0292
341 IMPAIRED GASTRIC EMPTYING 398 0.0292
342 POLLAKIURIA 1217 0.0292
343 HYPOTHERMIA 295 0.0291
344 PROTEINURIA 553 0.0291
345 DYSPNOEA 16455 0.0290
346 EMPHYSEMA 293 0.0290
347 RESPIRATORY FAILURE 2112 0.0289
348 LACERATION 272 0.0289
349 CELLULITIS 1456 0.0289
350 MUSCULOSKELETAL CHEST PAIN 447 0.0289
351 LETHARGY 1660 0.0288
352 URINARY TRACT INFECTION 4916 0.0288
353 DRY MOUTH 2337 0.0288
354 SLUGGISHNESS 293 0.0287
355 NERVE COMPRESSION 265 0.0287
356 HEAD INJURY 907 0.0286
357 MOUTH HAEMORRHAGE 210 0.0286
358 CARDIAC OPERATION 246 0.0286
359 WEIGHT DECREASED 7988 0.0286
360 CEREBROVASCULAR ACCIDENT 4844 0.0286
361 GROIN PAIN 251 0.0286
362 PERIPHERAL SWELLING 4397 0.0285
363 DYSPEPSIA 2807 0.0285
364 ULCER HAEMORRHAGE 193 0.0285
365 CARPAL TUNNEL SYNDROME 399 0.0285
366 HAEMOPTYSIS 794 0.0284
367 INITIAL INSOMNIA 292 0.0284
368 THYROID DISORDER 438 0.0284
369 BLOOD GLUCOSE DECREASED 1362 0.0283
370 ADRENAL INSUFFICIENCY 344 0.0283
371 ORAL PAIN 634 0.0283
372 HAEMORRHAGE INTRACRANIAL 423 0.0283
373 MUSCULAR WEAKNESS 3215 0.0283
374 GINGIVAL BLEEDING 386 0.0282
375 SUDDEN DEATH 299 0.0282
376 PEMPHIGOID 213 0.0282
377 JOINT DISLOCATION 298 0.0282
378 CONFUSIONAL STATE 4551 0.0281
379 MUSCULOSKELETAL DISCOMFORT 484 0.0281
380 COLD SWEAT 494 0.0280
381 SINUS CONGESTION 378 0.0280
382 RIB FRACTURE 575 0.0279
383 HAEMATOCHEZIA 1537 0.0278
384 SPLENOMEGALY 326 0.0278
385 JOINT RANGE OF MOTION DECREASED 373 0.0278
386 PALPITATIONS 3256 0.0278
387 ELECTROCARDIOGRAM QT PROLONGED 1000 0.0278
388 LIPASE INCREASED 213 0.0278
389 PULMONARY MASS 414 0.0278
390 RESTLESS LEGS SYNDROME 505 0.0277
391 BRONCHITIS 2054 0.0277
392 OSTEOPENIA 421 0.0277
393 HOSPICE CARE 273 0.0276
394 FLUSHING 2803 0.0275
395 SPINAL COMPRESSION FRACTURE 227 0.0274
396 UPPER-AIRWAY COUGH SYNDROME 226 0.0274
397 DIVERTICULITIS 760 0.0274
398 MUSCLE STRAIN 237 0.0274
399 CEREBRAL HAEMORRHAGE 980 0.0273
400 BLOOD ALKALINE PHOSPHATASE INCREASED 679 0.0273
401 SKIN LACERATION 297 0.0273
402 DYSSTASIA 796 0.0272
403 DYSARTHRIA 1026 0.0272
404 HYDRONEPHROSIS 204 0.0272
405 BALANCE DISORDER 2353 0.0272
406 TOOTH FRACTURE 300 0.0272
407 LOSS OF CONSCIOUSNESS 3483 0.0272
408 RHINITIS 219 0.0271
409 FLATULENCE 1538 0.0271
410 HYPOKINESIA 393 0.0270
411 HYPOTHYROIDISM 863 0.0270
412 SEASONAL ALLERGY 382 0.0270
413 MYOSITIS 242 0.0269
414 DISORIENTATION 1065 0.0268
415 ACTIVITIES OF DAILY LIVING IMPAIRED 532 0.0268
416 CONCUSSION 208 0.0268
417 LIMB INJURY 729 0.0268
418 PALLOR 730 0.0268
419 BLADDER DISORDER 266 0.0268
420 RESPIRATORY DISTRESS 739 0.0267
421 LOCAL SWELLING 466 0.0267
422 DYSPHONIA 1556 0.0266
423 INCONTINENCE 281 0.0266
424 OSTEOMYELITIS 481 0.0265
425 WHITE BLOOD CELL COUNT INCREASED 1019 0.0265
426 MUSCLE ATROPHY 336 0.0265
427 ERECTILE DYSFUNCTION 681 0.0265
428 SQUAMOUS CELL CARCINOMA 248 0.0263
429 HYPOPHAGIA 672 0.0263
430 DENTAL CARIES 290 0.0262
431 LIMB DISCOMFORT 810 0.0262
432 GALLBLADDER DISORDER 467 0.0261
433 PROSTATIC SPECIFIC ANTIGEN INCREASED 360 0.0261
434 NECK PAIN 1460 0.0261
435 MICTURITION URGENCY 297 0.0260
436 C-REACTIVE PROTEIN INCREASED 946 0.0260
437 DECREASED APPETITE 6024 0.0259
438 CONTRAINDICATED PRODUCT ADMINISTERED 785 0.0259
439 HEART RATE INCREASED 2567 0.0259
440 VAGINAL DISCHARGE 262 0.0259
441 MUSCLE DISORDER 209 0.0258
442 HYPERHIDROSIS 3321 0.0258
443 HEPATOMEGALY 253 0.0257
444 BACK PAIN 5976 0.0257
445 RETCHING 548 0.0257
446 CHROMATURIA 580 0.0257
447 CHOLECYSTITIS 306 0.0257
448 SWOLLEN TONGUE 802 0.0257
449 SMALL INTESTINAL OBSTRUCTION 316 0.0256
450 VITREOUS FLOATERS 252 0.0256
451 ARTHRITIS 2015 0.0256
452 CEREBRAL INFARCTION 625 0.0256
453 LOCALISED INFECTION 618 0.0255
454 BACK DISORDER 415 0.0255
455 FURUNCLE 202 0.0255
456 HALLUCINATION, VISUAL 538 0.0255
457 PRURITUS GENERALISED 551 0.0255
458 CONSTIPATION 5553 0.0254
459 ANKLE FRACTURE 394 0.0254
460 BLOOD CALCIUM INCREASED 223 0.0254
461 SINUS TACHYCARDIA 361 0.0254
462 FEELING COLD 707 0.0254
463 HIP FRACTURE 816 0.0253
464 CHEST DISCOMFORT 2598 0.0253
465 HEMIPARESIS 429 0.0253
466 COUGH 7096 0.0253
467 MYALGIA 4301 0.0253
468 BODY TEMPERATURE DECREASED 248 0.0252
469 HYPERSOMNIA 722 0.0252
470 DRUG LEVEL INCREASED 416 0.0251
471 HEMIPLEGIA 209 0.0251
472 TRANSFUSION 263 0.0251
473 GAIT DISTURBANCE 4797 0.0250
474 LIVER FUNCTION TEST ABNORMAL 728 0.0250
475 SEPTIC SHOCK 1089 0.0250
476 DEPRESSED LEVEL OF CONSCIOUSNESS 990 0.0250
477 GASTROENTERITIS 365 0.0250
478 PAIN IN EXTREMITY 7355 0.0249
479 OSTEOPOROSIS 1023 0.0248
480 STAPHYLOCOCCAL INFECTION 820 0.0248
481 SYNOVITIS 448 0.0248
482 POST PROCEDURAL COMPLICATION 477 0.0248
483 DIARRHOEA 16028 0.0248
484 MASS 347 0.0248
485 PNEUMONIA 8014 0.0247
486 CYANOSIS 389 0.0247
487 VERTIGO 1506 0.0247
488 PYELONEPHRITIS 214 0.0247
489 ANAL INCONTINENCE 222 0.0247
490 LIGAMENT SPRAIN 244 0.0247
491 OXYGEN SATURATION DECREASED 1386 0.0246
492 EATING DISORDER 525 0.0246
493 AGEUSIA 615 0.0246
494 MIDDLE INSOMNIA 459 0.0246
495 ASPARTATE AMINOTRANSFERASE INCREASED 1304 0.0245
496 ACUTE RESPIRATORY DISTRESS SYNDROME 434 0.0245
497 RENAL PAIN 260 0.0245
498 HELICOBACTER INFECTION 252 0.0245
499 URINARY RETENTION 818 0.0245
500 BLOOD GLUCOSE INCREASED 4619 0.0245
501 GINGIVAL PAIN 195 0.0245
502 NERVOUSNESS 1280 0.0245
503 PRESCRIBED UNDERDOSE 488 0.0244
504 HYPOALBUMINAEMIA 190 0.0244
505 BACTERAEMIA 290 0.0244
506 KIDNEY INFECTION 479 0.0244
507 BLOOD TEST ABNORMAL 342 0.0243
508 CYSTITIS 775 0.0243
509 BLOOD COUNT ABNORMAL 369 0.0243
510 PULMONARY THROMBOSIS 264 0.0242
511 NEPHROLITHIASIS 1108 0.0241
512 POST PROCEDURAL HAEMORRHAGE 280 0.0240
513 SINUS DISORDER 476 0.0240
514 FREQUENT BOWEL MOVEMENTS 649 0.0240
515 FEELING HOT 1471 0.0240
516 PRODUCTIVE COUGH 1143 0.0239
517 JOINT SWELLING 2877 0.0238
518 COLITIS 903 0.0238
519 SEPSIS 2646 0.0237
520 THIRST 423 0.0237
521 PHARMACEUTICAL PRODUCT COMPLAINT 614 0.0236
522 FATIGUE 18398 0.0236
523 PLATELET COUNT DECREASED 2517 0.0236
524 ENCEPHALOPATHY 579 0.0236
525 GLAUCOMA 454 0.0236
526 AMNESIA 1531 0.0235
527 ALANINE AMINOTRANSFERASE INCREASED 1443 0.0235
528 MUSCLE SPASMS 4307 0.0234
529 RESPIRATORY RATE INCREASED 208 0.0234
530 DYSPHAGIA 2210 0.0233
531 ARTHROPATHY 1292 0.0232
532 OBSTRUCTIVE AIRWAYS DISORDER 258 0.0232
533 DYSGEUSIA 1722 0.0232
534 ABDOMINAL DISTENSION 2418 0.0231
535 SPINAL FRACTURE 464 0.0231
536 CHOKING 451 0.0231
537 WRIST FRACTURE 277 0.0231
538 JAUNDICE 621 0.0231
539 NEUROPATHY PERIPHERAL 2186 0.0230
540 BLINDNESS UNILATERAL 323 0.0229
541 JOINT INJURY 489 0.0229
542 FOOT FRACTURE 434 0.0229
543 ASPIRATION 250 0.0228
544 HYPERTHYROIDISM 330 0.0228
545 SKIN DISCOLOURATION 1047 0.0228
546 DRY THROAT 231 0.0227
547 RESPIRATORY ARREST 626 0.0227
548 INJURY 1593 0.0226
549 SCAR 387 0.0226
550 HERNIA 437 0.0226
551 TOOTH ABSCESS 230 0.0226
552 APHASIA 682 0.0226
553 FEMUR FRACTURE 697 0.0225
554 TREATMENT NONCOMPLIANCE 1229 0.0224
555 VASCULITIS 261 0.0224
556 VISION BLURRED 3072 0.0224
557 HOT FLUSH 1686 0.0223
558 RASH PRURITIC 1211 0.0223
559 BLOOD BILIRUBIN INCREASED 602 0.0223
560 PANCREATITIS 1175 0.0222
561 MYOCLONUS 265 0.0222
562 NERVE INJURY 247 0.0222
563 ERUCTATION 429 0.0221
564 NEUTROPHIL COUNT INCREASED 227 0.0221
565 DEAFNESS 579 0.0221
566 FIBROMYALGIA 538 0.0221
567 ABDOMINAL PAIN 5141 0.0221
568 TACHYCARDIA 1963 0.0221
569 IMPAIRED HEALING 725 0.0221
570 DRUG TOXICITY 300 0.0220
571 PNEUMONIA BACTERIAL 202 0.0220
572 THROMBOSIS 1768 0.0220
573 RESPIRATORY TRACT CONGESTION 349 0.0219
574 DEPRESSION 4994 0.0219
575 ABNORMAL DREAMS 606 0.0219
576 THROAT IRRITATION 982 0.0219
577 SPEECH DISORDER 1146 0.0219
578 INSOMNIA 5822 0.0218
579 UPPER LIMB FRACTURE 435 0.0218
580 HEAD DISCOMFORT 386 0.0218
581 NEURALGIA 529 0.0217
582 DEEP VEIN THROMBOSIS 1411 0.0217
583 PNEUMONIA ASPIRATION 542 0.0217
584 ABDOMINAL PAIN UPPER 4466 0.0217
585 SPINAL PAIN 254 0.0217
586 EYE PAIN 1223 0.0217
587 HYPOAESTHESIA 3242 0.0216
588 TINNITUS 995 0.0216
589 FOOT DEFORMITY 240 0.0216
590 SWELLING FACE 1409 0.0216
591 BLOOD THYROID STIMULATING HORMONE INCREASED 199 0.0216
592 FEELING JITTERY 412 0.0216
593 BACK INJURY 235 0.0216
594 BURNING SENSATION 1514 0.0216
595 ORAL DISCOMFORT 300 0.0216
596 WEIGHT INCREASED 4823 0.0215
597 PARAESTHESIA 3387 0.0215
598 PHARYNGEAL OEDEMA 331 0.0215
599 CHOLESTASIS 413 0.0215
600 RHINORRHOEA 1390 0.0215
601 VISUAL ACUITY REDUCED 714 0.0215
602 POISONING 270 0.0215
603 SOMNOLENCE 4327 0.0215
604 ABDOMINAL DISCOMFORT 3601 0.0214
605 BLOOD GLUCOSE ABNORMAL 396 0.0214
606 SKIN LESION 588 0.0214
607 THROMBOCYTOPENIA 2397 0.0214
608 ATAXIA 254 0.0214
609 PLATELET COUNT INCREASED 279 0.0214
610 TOOTHACHE 387 0.0214
611 PANCYTOPENIA 1193 0.0213
612 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 203 0.0212
613 PAIN IN JAW 602 0.0212
614 EOSINOPHILIA 372 0.0212
615 PERITONITIS BACTERIAL 214 0.0212
616 UNEVALUABLE EVENT 1598 0.0211
617 ANXIETY 6009 0.0211
618 SWELLING 1976 0.0211
619 BRONCHOSPASM 301 0.0211
620 TACHYPNOEA 286 0.0210
621 GASTRIC HAEMORRHAGE 242 0.0210
622 UPPER RESPIRATORY TRACT INFECTION 968 0.0209
623 ANGIOEDEMA 926 0.0209
624 IMMUNODEFICIENCY 312 0.0209
625 PROCEDURAL PAIN 579 0.0209
626 NAUSEA 16518 0.0208
627 SCAB 238 0.0208
628 HEPATITIS 533 0.0208
629 FEELING ABNORMAL 4974 0.0207
630 DRUG-INDUCED LIVER INJURY 651 0.0207
631 BEDRIDDEN 272 0.0207
632 LIVER DISORDER 917 0.0207
633 GAMMA-GLUTAMYLTRANSFERASE INCREASED 458 0.0206
634 GASTRIC DISORDER 709 0.0206
635 BREAST PAIN 220 0.0206
636 QUALITY OF LIFE DECREASED 276 0.0206
637 LACRIMATION INCREASED 620 0.0205
638 IRRITABLE BOWEL SYNDROME 440 0.0205
639 MUSCLE TIGHTNESS 332 0.0205
640 WHEEZING 1214 0.0205
641 DEMENTIA 572 0.0204
642 CLOSTRIDIUM DIFFICILE INFECTION 446 0.0204
643 IMPAIRED DRIVING ABILITY 232 0.0204
644 ARTHRALGIA 8484 0.0204
645 MEDICATION ERROR 1131 0.0203
646 SENSORY DISTURBANCE 326 0.0203
647 EAR DISCOMFORT 208 0.0202
648 MEMORY IMPAIRMENT 2781 0.0202
649 SOPOR 268 0.0202
650 MALAISE 8867 0.0202
651 CARDIOVASCULAR DISORDER 513 0.0202
652 PHOTOPHOBIA 380 0.0202
653 ILEUS 251 0.0202
654 PARALYSIS 289 0.0202
655 HALLUCINATION 1518 0.0201
656 HALLUCINATION, AUDITORY 320 0.0201
657 GAIT INABILITY 673 0.0201
658 TOOTH INFECTION 264 0.0200
659 LUNG DISORDER 981 0.0200
660 TOOTH DISORDER 445 0.0200
661 NODULE 261 0.0200
662 GASTROENTERITIS VIRAL 361 0.0200
663 POOR QUALITY SLEEP 429 0.0199
664 WOUND 556 0.0199
665 MOBILITY DECREASED 1428 0.0199
666 EAR PAIN 385 0.0198
667 JOINT STIFFNESS 519 0.0198
668 BLISTER 1111 0.0198
669 PULMONARY EMBOLISM 1875 0.0197
670 BONE PAIN 1154 0.0197
671 NASAL CONGESTION 1157 0.0197
672 PHARYNGITIS 244 0.0197
673 APHONIA 274 0.0196
674 LABORATORY TEST ABNORMAL 579 0.0196
675 CYST 243 0.0196
676 DIPLOPIA 508 0.0195
677 LIP SWELLING 651 0.0195
678 GENERAL PHYSICAL HEALTH DETERIORATION 2260 0.0195
679 NIGHT SWEATS 628 0.0195
680 RASH GENERALISED 504 0.0194
681 DEPRESSED MOOD 1028 0.0194
682 TREMOR 3222 0.0194
683 GASTROINTESTINAL PAIN 213 0.0193
684 WOUND INFECTION 212 0.0193
685 TASTE DISORDER 392 0.0193
686 TOXICITY TO VARIOUS AGENTS 3258 0.0193
687 SINUSITIS 1976 0.0193
688 FEEDING DISORDER 391 0.0193
689 MOVEMENT DISORDER 619 0.0193
690 DELIRIUM 669 0.0193
691 MUSCULOSKELETAL STIFFNESS 1688 0.0192
692 VOMITING 9050 0.0192
693 BACTERIAL INFECTION 359 0.0192
694 LOWER LIMB FRACTURE 369 0.0192
695 HEADACHE 12015 0.0191
696 SCRATCH 202 0.0191
697 HAEMORRHAGE 1998 0.0191
698 INTERSTITIAL LUNG DISEASE 924 0.0191
699 RESPIRATORY DEPRESSION 233 0.0190
700 COLON CANCER 282 0.0189
701 WRONG TECHNIQUE IN DRUG USAGE PROCESS 684 0.0188
702 NO THERAPEUTIC RESPONSE 229 0.0188
703 COMA 893 0.0187
704 HEPATIC ENZYME INCREASED 1276 0.0187
705 CANDIDA INFECTION 316 0.0187
706 TENDON RUPTURE 231 0.0187
707 ALOPECIA 3662 0.0186
708 DRUG ERUPTION 330 0.0186
709 CHILLS 2182 0.0186
710 RASH MACULAR 650 0.0186
711 DEVICE RELATED INFECTION 286 0.0186
712 THINKING ABNORMAL 346 0.0186
713 PAIN 11387 0.0185
714 DRUG INTOLERANCE 1775 0.0184
715 SKIN HAEMORRHAGE 272 0.0183
716 PHOTOSENSITIVITY REACTION 302 0.0183
717 INFUSION RELATED REACTION 1211 0.0183
718 SKIN DISORDER 609 0.0182
719 INFLUENZA 2036 0.0182
720 SKIN CANCER 393 0.0182
721 EYE INFECTION 206 0.0182
722 IMPAIRED QUALITY OF LIFE 262 0.0182
723 DRUG PRESCRIBING ERROR 350 0.0182
724 ROAD TRAFFIC ACCIDENT 762 0.0182
725 TENDONITIS 282 0.0182
726 PRODUCT PRESCRIBING ERROR 433 0.0182
727 CAESAREAN SECTION 211 0.0181
728 SLEEP DISORDER 1279 0.0181
729 RASH MACULO-PAPULAR 403 0.0181
730 HYPOACUSIS 779 0.0181
731 FUNGAL INFECTION 602 0.0180
732 NIGHTMARE 625 0.0180
733 AGRANULOCYTOSIS 335 0.0180
734 HEPATIC FAILURE 543 0.0180
735 RESPIRATORY TRACT INFECTION 469 0.0180
736 WHITE BLOOD CELL COUNT DECREASED 1951 0.0180
737 STOMATITIS 1089 0.0179
738 HERPES ZOSTER 1031 0.0179
739 MUSCLE TWITCHING 413 0.0179
740 OROPHARYNGEAL PAIN 1657 0.0179
741 HYPOAESTHESIA ORAL 269 0.0178
742 INJECTION SITE NODULE 196 0.0178
743 COGNITIVE DISORDER 828 0.0177
744 VIRAL INFECTION 590 0.0177
745 NEPHROPATHY TOXIC 199 0.0177
746 MALIGNANT MELANOMA 237 0.0177
747 DRY EYE 882 0.0177
748 RESPIRATORY DISORDER 528 0.0176
749 DYSKINESIA 717 0.0176
750 EYE DISORDER 580 0.0176
751 LUNG INFECTION 274 0.0176
752 COVID-19 PNEUMONIA 208 0.0176
753 TRANSAMINASES INCREASED 391 0.0176
754 ABDOMINAL PAIN LOWER 444 0.0175
755 INFLAMMATION 905 0.0175
756 METASTASES TO LUNG 202 0.0175
757 ALTERED STATE OF CONSCIOUSNESS 378 0.0174
758 TOOTH EXTRACTION 217 0.0174
759 CHOLECYSTECTOMY 199 0.0174
760 GLOSSODYNIA 390 0.0174
761 PRURITUS 6686 0.0174
762 HEPATOCELLULAR INJURY 246 0.0173
763 INCREASED APPETITE 331 0.0173
764 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 830 0.0173
765 PULMONARY ARTERIAL HYPERTENSION 250 0.0172
766 SECRETION DISCHARGE 216 0.0172
767 PRODUCT SUBSTITUTION ISSUE 991 0.0172
768 DRUG ADMINISTRATION ERROR 528 0.0172
769 METASTASES TO BONE 282 0.0172
770 ACCIDENT 205 0.0171
771 THERAPEUTIC RESPONSE UNEXPECTED 770 0.0171
772 SNEEZING 382 0.0170
773 CONVULSION 967 0.0169
774 NEOPLASM 194 0.0169
775 EYE SWELLING 626 0.0168
776 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1196 0.0168
777 BLOOD LACTATE DEHYDROGENASE INCREASED 266 0.0168
778 INTENTIONAL DRUG MISUSE 350 0.0167
779 CONDITION AGGRAVATED 5083 0.0167
780 INTENTIONAL OVERDOSE 1072 0.0167
781 MENTAL IMPAIRMENT 405 0.0167
782 PRODUCT TASTE ABNORMAL 226 0.0167
783 KNEE ARTHROPLASTY 351 0.0167
784 AGITATION 1223 0.0166
785 MUSCLE RIGIDITY 199 0.0166
786 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 427 0.0166
787 PYREXIA 5741 0.0166
788 THROAT TIGHTNESS 447 0.0165
789 LYMPHADENOPATHY 583 0.0165
790 DERMATITIS 345 0.0164
791 PNEUMOTHORAX 261 0.0164
792 LYMPHOCYTE COUNT DECREASED 290 0.0164
793 INTESTINAL OBSTRUCTION 617 0.0164
794 BLINDNESS 665 0.0163
795 VISUAL IMPAIRMENT 2018 0.0163
796 PNEUMONITIS 443 0.0163
797 BODY TEMPERATURE INCREASED 331 0.0162
798 MYELODYSPLASTIC SYNDROME 234 0.0162
799 PLASMA CELL MYELOMA 631 0.0162
800 SPINAL OPERATION 199 0.0161
801 PERITONITIS 334 0.0161
802 DELUSION 250 0.0161
803 PANIC ATTACK 586 0.0161
804 HIP ARTHROPLASTY 246 0.0160
805 DISSEMINATED INTRAVASCULAR COAGULATION 225 0.0160
806 ERYTHEMA 3277 0.0159
807 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 371 0.0159
808 DISABILITY 314 0.0159
809 DISTURBANCE IN ATTENTION 853 0.0158
810 INTENTIONAL DOSE OMISSION 450 0.0158
811 RESTLESSNESS 574 0.0157
812 METASTASES TO LIVER 275 0.0156
813 TOXIC EPIDERMAL NECROLYSIS 237 0.0156
814 DRUG DOSE OMISSION 2576 0.0156
815 THERAPY CESSATION 793 0.0154
816 STEVENS-JOHNSON SYNDROME 342 0.0154
817 BRAIN OEDEMA 194 0.0153
818 FOETAL EXPOSURE DURING PREGNANCY 1245 0.0153
819 DRUG EFFECT DECREASED 822 0.0152
820 IMMUNE SYSTEM DISORDER 200 0.0152
821 HEPATIC CYTOLYSIS 193 0.0151
822 RASH 6588 0.0151
823 INSURANCE ISSUE 231 0.0151
824 PRESCRIBED OVERDOSE 290 0.0150
825 GASTROINTESTINAL DISORDER 1342 0.0150
826 MUCOSAL INFLAMMATION 391 0.0149
827 OCULAR HYPERAEMIA 706 0.0149
828 MULTIPLE ORGAN DYSFUNCTION SYNDROME 421 0.0148
829 RASH ERYTHEMATOUS 710 0.0148
830 INFECTION 2146 0.0148
831 EMOTIONAL DISORDER 457 0.0148
832 NASOPHARYNGITIS 2730 0.0148
833 INTENTIONAL PRODUCT MISUSE 1295 0.0148
834 PARANOIA 255 0.0148
835 OSTEONECROSIS OF JAW 366 0.0148
836 PRODUCT DOSE OMISSION 964 0.0148
837 MUSCULOSKELETAL DISORDER 281 0.0147
838 EYE IRRITATION 849 0.0147
839 EMOTIONAL DISTRESS 1776 0.0147
840 MULTIPLE FRACTURES 240 0.0146
841 ABSCESS 233 0.0146
842 THERAPY NON-RESPONDER 656 0.0146
843 SEDATION 381 0.0145
844 RHEUMATOID ARTHRITIS 1647 0.0145
845 MOUTH ULCERATION 305 0.0145
846 FACE OEDEMA 244 0.0145
847 EAR INFECTION 385 0.0145
848 EXPOSURE DURING PREGNANCY 899 0.0144
849 NERVOUS SYSTEM DISORDER 451 0.0144
850 HYPERSENSITIVITY 2670 0.0144
851 MATERNAL EXPOSURE DURING PREGNANCY 1277 0.0143
852 PRODUCT PHYSICAL ISSUE 289 0.0143
853 THERAPEUTIC RESPONSE DECREASED 867 0.0143
854 DRUG DISPENSING ERROR 218 0.0142
855 HUNGER 197 0.0141
856 SURGERY 824 0.0140
857 DISEASE PROGRESSION 1657 0.0140
858 PSORIATIC ARTHROPATHY 568 0.0140
859 CRYING 508 0.0140
860 PRODUCT AVAILABILITY ISSUE 318 0.0140
861 LEUKOPENIA 697 0.0139
862 BRAIN FOG 218 0.0139
863 RASH PAPULAR 311 0.0139
864 INFLUENZA LIKE ILLNESS 1140 0.0138
865 ANAPHYLACTIC REACTION 762 0.0138
866 PSYCHOTIC DISORDER 407 0.0138
867 PRODUCT USE ISSUE 2582 0.0137
868 ANOSMIA 198 0.0137
869 PSYCHOMOTOR HYPERACTIVITY 227 0.0137
870 ILL-DEFINED DISORDER 830 0.0136
871 GENERALISED TONIC-CLONIC SEIZURE 226 0.0136
872 LYMPHOMA 211 0.0136
873 SEROTONIN SYNDROME 261 0.0136
874 INCORRECT DRUG ADMINISTRATION DURATION 382 0.0136
875 MENTAL DISORDER 591 0.0136
876 DISCOMFORT 825 0.0135
877 ANAPHYLACTIC SHOCK 348 0.0135
878 MIGRAINE 1287 0.0135
879 IMPAIRED WORK ABILITY 288 0.0135
880 INTENTIONAL PRODUCT USE ISSUE 1180 0.0135
881 DIABETIC KETOACIDOSIS 322 0.0134
882 SUICIDE ATTEMPT 812 0.0134
883 APATHY 193 0.0132
884 PSORIASIS 1727 0.0132
885 IRRITABILITY 794 0.0132
886 SKIN EXFOLIATION 1112 0.0132
887 FEBRILE NEUTROPENIA 870 0.0131
888 COVID-19 2294 0.0131
889 ACCIDENTAL OVERDOSE 477 0.0130
890 URTICARIA 2179 0.0130
891 ABNORMAL BEHAVIOUR 515 0.0130
892 PRODUCT ADMINISTRATION ERROR 262 0.0130
893 SKIN FISSURES 253 0.0129
894 LOWER RESPIRATORY TRACT INFECTION 588 0.0129
895 DRUG EFFECT INCOMPLETE 469 0.0129
896 HEPATOTOXICITY 287 0.0129
897 PRODUCT QUALITY ISSUE 1749 0.0129
898 DRUG INEFFECTIVE 16969 0.0129
899 BONE MARROW FAILURE 260 0.0128
900 THERAPY INTERRUPTED 909 0.0127
901 LIVER FUNCTION TEST INCREASED 271 0.0126
902 NEUTROPENIA 1700 0.0125
903 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 682 0.0124
904 DISEASE RECURRENCE 591 0.0124
905 EYE PRURITUS 417 0.0124
906 ASTHMA 1399 0.0124
907 TOOTH LOSS 256 0.0123
908 ILLNESS 1268 0.0123
909 AGGRESSION 614 0.0123
910 OFF LABEL USE 10732 0.0122
911 PRODUCT DOSE OMISSION IN ERROR 342 0.0121
912 CONJUNCTIVITIS 222 0.0120
913 SEIZURE 1376 0.0119
914 MOOD ALTERED 324 0.0119
915 ORAL HERPES 230 0.0118
916 ADVERSE DRUG REACTION 1058 0.0118
917 HEPATIC FUNCTION ABNORMAL 436 0.0117
918 FRACTURE 221 0.0117
919 NEOPLASM PROGRESSION 406 0.0117
920 COLITIS ULCERATIVE 519 0.0116
921 WITHDRAWAL SYNDROME 486 0.0116
922 ADVERSE EVENT 1064 0.0115
923 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 818 0.0115
924 UNDERDOSE 839 0.0115
925 NEUTROPHIL COUNT DECREASED 467 0.0114
926 THERAPEUTIC PRODUCT EFFECT DECREASED 513 0.0114
927 DRY SKIN 1523 0.0114
928 HOSPITALISATION 1748 0.0114
929 BONE DENSITY DECREASED 356 0.0114
930 LUNG NEOPLASM MALIGNANT 467 0.0114
931 MALIGNANT NEOPLASM PROGRESSION 1154 0.0113
932 OVERDOSE 2424 0.0112
933 DEATH 9544 0.0111
934 PRODUCT DOSE OMISSION ISSUE 3225 0.0110
935 ANGER 366 0.0108
936 BREAST CANCER FEMALE 289 0.0108
937 APPLICATION SITE PRURITUS 242 0.0107
938 EXPIRED PRODUCT ADMINISTERED 353 0.0106
939 PELVIC PAIN 192 0.0106
940 INCORRECT DOSE ADMINISTERED 2371 0.0104
941 INJECTION SITE MASS 384 0.0104
942 SUICIDAL IDEATION 944 0.0103
943 PRODUCT USE IN UNAPPROVED INDICATION 2555 0.0103
944 PAIN OF SKIN 276 0.0102
945 LIVER INJURY 250 0.0102
946 EXTRAPYRAMIDAL DISORDER 250 0.0101
947 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2016 0.0099
948 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1789 0.0099
949 PRODUCT DISPENSING ERROR 212 0.0097
950 ECZEMA 500 0.0095
951 OSTEONECROSIS 313 0.0095
952 INJECTION SITE HAEMORRHAGE 760 0.0095
953 MULTIPLE SCLEROSIS 449 0.0094
954 NEOPLASM MALIGNANT 610 0.0091
955 APPLICATION SITE PAIN 195 0.0088
956 MOOD SWINGS 282 0.0088
957 VAGINAL HAEMORRHAGE 380 0.0087
958 APPLICATION SITE ERYTHEMA 229 0.0087
959 INJECTION SITE BRUISING 697 0.0087
960 INJECTION SITE PRURITUS 583 0.0087
961 NEEDLE ISSUE 249 0.0085
962 TARDIVE DYSKINESIA 241 0.0085
963 EPILEPSY 261 0.0085
964 DEVICE MALFUNCTION 591 0.0084
965 SYSTEMIC LUPUS ERYTHEMATOSUS 296 0.0083
966 THERAPEUTIC RESPONSE SHORTENED 271 0.0082
967 INJECTION SITE PAIN 2491 0.0081
968 INJECTION SITE ERYTHEMA 939 0.0076
969 EXTRA DOSE ADMINISTERED 304 0.0075
970 SKIN BURNING SENSATION 533 0.0074
971 GYNAECOMASTIA 227 0.0073
972 MULTIPLE SCLEROSIS RELAPSE 499 0.0073
973 INJECTION SITE RASH 222 0.0072
974 PANCREATIC CARCINOMA 206 0.0071
975 BREAST CANCER 649 0.0070
976 TREATMENT FAILURE 574 0.0069
977 INJECTION SITE REACTION 453 0.0066
978 INJECTION SITE SWELLING 499 0.0065
979 PRODUCT ADHESION ISSUE 230 0.0064
980 SKIN IRRITATION 284 0.0062
981 DRUG WITHDRAWAL SYNDROME 541 0.0062
982 DEVICE ISSUE 535 0.0060
983 DRUG EXPOSURE DURING PREGNANCY 199 0.0058
984 ACNE 430 0.0057
985 NO ADVERSE EVENT 1011 0.0056
986 DRUG ABUSE 461 0.0055
987 ABORTION SPONTANEOUS 219 0.0055
988 PROSTATE CANCER 415 0.0052
989 DEVICE DISLOCATION 206 0.0047
990 DERMATITIS ATOPIC 242 0.0046
991 RENAL CANCER 191 0.0040
992 ACCIDENTAL EXPOSURE TO PRODUCT 383 0.0037
993 BLADDER CANCER 203 0.0034
994 PRODUCT STORAGE ERROR 266 0.0030
995 DRUG DEPENDENCE 368 0.0023